✦ LIBER ✦

Monoclonal antibodies to malignant human gliomas

✍ Scribed by Carol J. Wikstrand; Pam Fredman; Lars Svennerholm; Peter A. Humphrey; Sandra H. Bigner; Darell D. Bigner

Book ID: 105718366
Publisher: Springer-Verlag
Year: 1992
Tongue: English
Weight: 742 KB
Volume: 17
Category: Article
ISSN: 1044-7393
DOI: 10.1007/bf03159988

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Human monoclonal antibodies to glioma ce

Human monoclonal antibodies to glioma cells

✍ Sikora, K; Phillips, J 📂 Article 📅 1981 🏛 Nature Publishing Group 🌐 English ⚖ 311 KB

Monoclonal antibodies to human malignant

Monoclonal antibodies to human malignant mesothelioma

✍ Timothy M. Anderson; E. Carmack Holmes; Calvin J. Kosaka; Lorna Cheng; Romaine E 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 732 KB

Monoclonal antibodies to human malignant

Monoclonal antibodies to human malignant melanoma

✍ Reisfeld, Ralph A. 📂 Article 📅 1982 🏛 Nature Publishing Group 🌐 English ⚖ 278 KB

Monoclonal antibodies to human erythrocy

Monoclonal antibodies to human erythrocytes

✍ David J. Anstee; Paul A. W. Edwards 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

Human monoclonal antibodies

✍ K.M. Thompson 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 747 KB

Human monoclonal antibodies

✍ S. P. C. Cole; B. G. Campling; T. Atlaw; D. Kozbor; J. C. Roder 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 939 KB

The technology for the production of murine monoclonal antibodies has been refined enormously since its introduction in 1975. However, the technology for generating human monoclonal antibodies has only recently come into its own. In this review, three currently available approaches to the production